Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol). Xamiol is a lipophilic gel specially formulated for the scalp. For efficacy, the proportion of patients whose psoriasis improved was always significantly higher in the two-compound group compared to the group treated with the individual substances.
MBL 0502 US: Calcipotriene plus betamethasone dipropionate gel compared to the gel vehicle in scalp psoriasis, in patients receiving calcipotriene plus betamethasone dipropionate ointment for psoriasis vulgaris of trunk/limbs Summary (PDF) Report (PDF). Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Both the ointment (Daivobet; Dovobet) and gel (Xamiol; Daivobet Gel; Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese populatio was found in Unbound MEDLINE. The purpose of this randomized, investigator-blinded, active-controlled, 4-week study was to evaluate the efficacy and safety of the two-compound gel in Chinese subjects with scalp psoriasis.
The gel vehicle was developed for ease of use, improved cosmetic acceptability and absorption on the scalp. 3 mild in 71.2 of the patients who were treated with Xamiol vs. 34 34.5 Xamiol 56.7 calcipotriol scalp solution (p0.001) 3.4 Xamiol vs. 0.005: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. One gram of gel contains 50 micrograms of calcipotriol (as monohydrate) and 0. Topical treatment of scalp psoriasis in adults. The safety and efficacy of Xamiol gel in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated. 001) Another randomised, investigator-blinded clinical study including 312 patients with scalp psoriasis of at least moderate severity according to the IGA investigated use of Xamiol gel once daily compared with Dovonex Scalp solution twice daily for up to 8 weeks. Efficacy and Safety of Xamiol Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis. Status: Completed. Study Phase: Phase 3.
BACKGROUND: Current topical therapies for scalp psoriasis are difficult or unpleasant to apply, resulting in decreased adherence and efficacy. OBJECTIVES: To compare the efficacy and safety of once-daily treatment with a combination of calcipotriol 50 microg g(-1) plus betamethasone 0. Xamiol(Betamethasone dipropionate + Calcipotriol): Topical treatment of scalp psoriasis. Parallel-group Study to Assess the Efficacy and Safety of Xamiol Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis. Next Previous. Nine-hundred and four patients were screened and randomised on a 1:1 basis in two groups: maintenance of two applications per week (group A) versus on-demand therapy (group B). Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Clinical Trials for Calcipotriene. A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) (Completed). Scalp psoriasis on ResearchGate, the professional network for scientists.
For Scalp Psoriasis With Emphasis On Calcipotriol Plus Betamethasone Dipropionate Gel (xamiol
Patients with scalp psoriasis suffered from a lower quality of life relating to the highly visible site of their psoriatic lesions. In conclusion, topical corticosteroids, calcipotriol, ciclopirox olamine and associations between them are effective in the treatment of scalp psoriasis. Efficacy and Safety Comparison of Clobetasol Propionate Shampoo, Gel and Vehicle in Scalp Psoriasis. Solution and Placebo Control in Treatment of Psoriasis of the Scalp. Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients. Scalp psoriasis: topical calcipotriol 50 micrograms/g/mlsolution vs. betamethasone valerate 1 lotion. Calcipotriene plus betamethasone dipropionate gel comparedto calcipotriene solution in patients with scalp psoriasis. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12 17 years of age.